Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Cruris
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
A research study to compare the safety and effectiveness of an investigational medication
called NAFT-500 to placebo (no active treatment), when used in subjects with tinea cruris,
also known as jock itch.
Phase:
Phase 3
Details
Lead Sponsor:
Merz North America, Inc. Merz Pharmaceuticals, LLC